Rather than issuing a recall, medical device managers rely on their physician-customers to screen out defective products and not use them on patients, a new behavioral study published in the Journal ...

Medical device firm managers trust physicians to screen out defects in lieu of recalls, a study conducted by Indianapolis-based Indiana University and Minneapolis-based University of Minnesota ...

Two million bone transplants are performed worldwide yearly, including half a million in the United States alone. Yet, a QUT-led study has found surgeons are slow to adopt newly developed biomaterials ...

Bone defects are a major challenge in regenerative medicine, often requiring advanced biomaterials to enhance the natural healing process. Traditional bone repair methods, including bone grafts, face ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that ...